Article Details
Retrieved on: 2024-04-25 12:41:35
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article suggests that tumor-derived extracellular vesicles (EVs) interfere with cancer treatments, including chemotherapy and immune therapies like pembrolizumab and nivolumab, by aiding in metastasis, evading the immune system, and drug resistance. Aethlon's Hemopurifier® aims to improve treatment outcomes by filtering these EVs.
Article found on: www.marketscreener.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here